-
公开(公告)号:US09050326B2
公开(公告)日:2015-06-09
申请号:US12415295
申请日:2009-03-31
IPC分类号: A61K31/41 , A01N43/82 , A61K31/421 , A61K9/14 , A61K9/16 , A61K31/4192 , A61K31/4245 , A61K31/4402
CPC分类号: A61K31/421 , A61K9/146 , A61K9/1652 , A61K31/4192 , A61K31/4245 , A61K31/4402
摘要: The present invention relates to a pharmaceutical composition containing a solid dispersion comprising an amide derivative or a salt thereof and a water-soluble polymer, wherein the pharmaceutical composition is not prepared by a melting method. The pharmaceutical composition contains the solid dispersion having an improved oral absorption, properties suitable for formulation, and an excellent stability.
摘要翻译: 本发明涉及含有含有酰胺衍生物或其盐和水溶性聚合物的固体分散体的药物组合物,其中药物组合物不是通过熔融法制备的。 药物组合物含有具有改善的口服吸收性,适于配制的性质和优异的稳定性的固体分散体。
-
公开(公告)号:US20090270463A1
公开(公告)日:2009-10-29
申请号:US12415295
申请日:2009-03-31
IPC分类号: A61K31/4245 , A61K31/422
CPC分类号: A61K31/421 , A61K9/146 , A61K9/1652 , A61K31/4192 , A61K31/4245 , A61K31/4402
摘要: The present invention relates to a pharmaceutical composition containing a solid dispersion comprising an amide derivative or a salt thereof and a water-soluble polymer, wherein the pharmaceutical composition is not prepared by a melting method. The pharmaceutical composition contains the solid dispersion having an improved oral absorption, properties suitable for formulation, and an excellent stability.
摘要翻译: 本发明涉及含有含有酰胺衍生物或其盐和水溶性聚合物的固体分散体的药物组合物,其中药物组合物不是通过熔融法制备的。 药物组合物含有具有改善的口服吸收性,适于配制的性质和优异的稳定性的固体分散体。
-